Evidence map›Paper›PMID 34792020›Full record

ArticleeLife2021

Hydrogen sulfide blocks HIV rebound by maintaining mitochondrial bioenergetics and redox homeostasis.

Virender Kumar Pal, Ragini Agrawal, Srabanti Rakshit, Pooja Shekar, Diwakar Tumkur Narasimha Murthy, Annapurna Vyakarnam, Amit Singh

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 16 citations in OpenAlex.

  1. HIV-1 gp120-induced lysosomal stress responses are controlled by TRPML1 redox sensors.Redox report : communications in free radical research · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Intersection of HNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  8. Sulfide regulation and catabolism in health and disease.Signal transduction and targeted therapy · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Virender Kumar PalDepartment of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India.ORCID 0000-0001-8378-1823
Ragini AgrawalDepartment of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India.
Srabanti RakshitCentre for Infectious Disease Research (CIDR), Indian Institute of Science, Bangalore, India.
Pooja ShekarBangalore Medical College and Research Institute, Bangalore, India.
Diwakar Tumkur Narasimha MurthyDepartment of Internal Medicine, Bangalore Medical College and Research Institute, Bangalore, India.
Annapurna VyakarnamCentre for Infectious Disease Research (CIDR), Indian Institute of Science, Bangalore, India.
Amit SinghDepartment of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India.ORCID 0000-0001-6761-1664
Wellcome Centre for Infectious Diseases Research in Africa · ZABangalore Medical College and Research Institute · INGuy's Hospital · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

A fundamental challenge in human immunodeficiency virus (HIV) eradication is to understand how the virus establishes latency, maintains stable cellular reservoirs, and promotes rebound upon interruption of antiretroviral therapy (ART). Here, we discovered an unexpected role of the ubiquitous gasotransmitter hydrogen sulfide (H

Indexed as

Energy MetabolismHomeostasisHIVHydrogen SulfideMitochondriaMorpholinesOrganothiophosphorus CompoundsOxidation-ReductionVirus LatencyVirus ReplicationGYY 4137Hydrogen SulfideMorpholinesOrganothiophosphorus Compoundsbiochemistrychemical biologycystathionine-gamma-lyasegasotransmitterGYY4137infectious diseaselatencymicrobiologyredoxT-cellsviruses

Identifiers

PMID34792020
PMCPMC8660018
OpenAlexW3212731060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.